CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Sleep ALL Nightbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05866887
NCT05866887N/ACompleted
CompareCT.gov

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Dana-Farber Cancer Institute·interventional·Posted May 19, 2023·Updated Jun 6, 2025

In Brief

A clinical study evaluating Sleep ALL Night for Pediatric Acute Lymphoblastic Leukemia and 2 related conditions. Completed, enrolled 25 participants across 2 sites.

Detailed Summary

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202420252026
First PostedMay 19, 2023
Enrollment StartSep 26, 2023
Primary CompletionJun 5, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.1 years ago

Interventions

Sleep ALL Nightbehavioral

Sleep intervention program comprised of a sleep action plan tool and interactive psychoeducation website.